Alembic Q1FY27: PAT slips, associate share lifts consolidated profit

Emphasis Of MatterRevenue DeclineResults View source PDF Explain this filing

ALEMBICLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.0%Reaction day

₹86.88

prior close

₹86.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-2.4% vs market

Residential Commercial Projects peers, median of 64sector-0.9%-1.2% vs sector

On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 1.2 pts less than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.1

10m

-2.0

15m

-2.1

30m

-1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.0+0.4-2.4-0.9-1.2

Next day

-4.2+0.5-4.8-0.3-4.0

+0.4+0.6-0.2-0.3+0.7

+3.6+0.7+2.9+0.5+3.2

+3.1+1.1+2.0-0.4+3.6

+1.9+0.5+1.4-1.6+3.6

+6.8+1.3+5.5-0.4+7.3

15d

+15.3+0.5+14.8-3.5+18.8

+15.2-0.8+16.1-7.4+22.6

+16.1-0.9+17.1-8.2+24.3

—————

UpDownMarket · Nifty Microcap 250Sector · Residential Commercial Projects peers, median of 64Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alembic Limited posted Q1FY27 unaudited results for quarter ended June 30, 2026. Consolidated revenue slipped to Rs 4,874 lakhs versus Rs 4,975 lakhs year ago. Consolidated PAT at Rs 1,570 lakhs versus Rs 1,780 lakhs. Including associate Alembic Pharma share, net profit rose to Rs 6,489 lakhs versus Rs 6,164 lakhs. Standalone PAT at Rs 1,468 lakhs versus Rs 1,712 lakhs. Auditors flagged an emphasis of matter on an electricity duty dispute, with Rs 2,052 lakhs provisioned and Rs 35 crore deposited with the Supreme Court.

Likely market impact

Mixed quarter with revenue and PAT down YoY. Associate Alembic Pharma cushions consolidated profit. Electricity duty case remains a watched contingent liability.